baber/WOPTO huggingface dataset:
Patent FI-844969-A0 (FI)
Inventor: FITZGERALD CHARLES S
IPC: G02B23/26
Filed: 1984-12-14
Abstract: A probe (10) for inspecting the inner surface of a tube (40) utilises a group of large diameter optical fibres (12) as a light source and an annular ring (14) of smaller diameter optical fibres as interceptors of the reflected light. A pair of plano-convex lenses (16) focuses a light beam (42) emanating from the group of large diameter optical fibres (12) onto a reflective ball bearing (18) or a concave cone (32) causing a circumferential band (44) to be illuminated on the inner surface of the tube (40). Light from the band (44) is intercepted by the optical fibres within the annular ring (14) and is transmitted therethrough. The transfer of light from the band (44) to the annular ring (14) can be optimised by bevelling the end of the optical fibres (14) within the annular ring.
Patent FI-850834-A0 (FI)
Inventor: GROSS LAURENCE HERBERT
IPC: C08F10/00
Filed: 1985-02-28
Abstract: Solid polyolefin catalysts are adapted for use in low pressure gas phase fluid bed polymerization processes by being mixed with selected particulate organic support materials in a high speed bladed finishing device so as to cause the catalysts materials to become embedded in, and/or adhered to, softened particles of the support material.
Patent FI-853560-A0 (FI)
Inventor: HOFMEISTER HELMUT
IPC: C07J63/00
Filed: 1985-09-17
Abstract: Known pregnane derivatives are prepared by esterificiation of known androstane derivatives to give new ester of Formula III    <IMAGE> (III)  wherein    in each case symbolizes a single bond or a double bond, n is 1 or 2, R1 is hydrogen or methyl, R2 is hydrogen or formyl, and R3 is chlorine, hydroxy or an alkanoyloxy group of up to 6 carbon atoms, and reaction of the latter with Ag(I) and formic acid.
Patent FI-883247-A0 (FI)
Inventor: JENDRALLA HEINER
IPC: C07D207/333
Filed: 1988-07-07
Abstract: 7-[1H-Pyrrol-3-yl]-substituted 3,5-dihydroxyhept-6-enoic acids and 7-[1H-pyrrol-3-yl]-substituted 3,5-dihydroxyheptanoic acids of the formula I 
<IMAGE>
 in which A, B, R<1>, R<2>, R<3>, R<4> and R<5> have the meanings given, and the corresponding  delta -lactones of the formula II 
<IMAGE>
 are described.
Patent FI-892831-A0 (FI)
Inventor: BLEMBERG ROBERT JOHN
IPC: B29C48/495
Filed: 1989-06-08
Abstract: Method and apparatus for fabricating multiple layer sheet materials are adapted to minimize the time of exposure of a sensitive polymeric melt stream to contact with metal. The method comprises encapsulating the sensitive melt stream (12) with a second polymeric melt stream (16) which preferably is of a lower viscosity, at the outlet of the apparatus or extruder (10) which produces the sensitive melt stream (12). When the encapsulating melt stream (16) has a lower viscosity than the sensitive melt stream, a transport means (36) - an elongated pipe - is preferably employed between the encapsulating means (20) and an extrusion die (42), whereby thickness variations about the circumference of the encapsulating melt stream (16) are reduced. The method and apparatus are especially beneficial for the extrusion of vinylidene chloride copolymers in the manufacture of multi-layer packaging films containing one or more layers of VDC copolymers. <IMAGE>   <IMAGE>
Patent FI-893399-A0 (FI)
Inventor: CHARMAN NEIL JOHN
IPC: G06K7/06
Filed: 1989-07-13
Abstract: A very slim and generally compact card reader for use with a so-called "smart card", i.e. having an integrated circuit connected to external contact pads to enable stored information to be read. A carriage (3) is slidably mounted in a chassis (2) and an abutment (4) supports and guides the card as it is inserted into the reader. Card reading contacts (13a) are supported by a plinth (13b) which is spaced from the card (1) when the carriage is in an initial card receiving position (see Figure 4a). Insertion of a card into the reader causes the carriage to slide along a lazy Z-shaped path (8) generally in the direction of card insertion towards a final card reading position (see Figure 4b) and the carriage thus presses the card against the abutment (4) causing the card to bend so that the contact pads are urged into engagement with the contacts on the plinth. Deflectable fingers (11,21) on the carriage or the chassis grip the card and help to maintain both the card and the carriage in the card reading position.
Patent FI-901291-A0 (FI)
Inventor: HOFFMANN ANNEGRETE
IPC: A61L15/44
Filed: 1990-03-15
Abstract: Transdermal patches for controlled release of a drug comprise at least one drug reservoir in contg. with a drug-contg. release-controlling matrix, with a backing layer on the skin-distal side of the matrix and an adhesive layer on the skin-proximal side. The size and posn. of each drug reservoir are such that in at least one direction, the distance between the reservoir and the drug delivery surface of the matrix is greater than the diffusion path length of at least one drug from its reservoir into the matrix during the period of application.
Patent FI-903607-A0 (FI)
Inventor: KANTNER ROBERT CAMPBELL
IPC: C22C47/08
Filed: 1990-07-17
Abstract: The present invention relates to a novel process for forming metal matrix composite bodies. Particularly, a suitable matrix metal (33), typically in a molten state, is in contact with a suitable filler material (31) or preform in the presence of a suitable reactive atmosphere in an impermeable container (32), at least at some point during the process, which permits a reaction to occur between the reactive atmosphere and the molten matrix metal (33) and /or filler material (31) or preform and/or impermeable container (32), thereby causing molten matrix metal (33) to infiltrate the filler material (31) or preform due to, at least in part, the creation of a self-generated vacuum. Such self-generated vacuum infiltration occurs without the application of any external pressure or vacuum.
Patent FI-912899-A0 (FI)
Inventor: LAVASTRE SERGE
IPC: C07D295/084
Filed: 1991-06-14
Abstract: The invention relates to hexahydroazepine derivatives of formula: <IMAGE>  in which:   - A is a group chosen from the following: -CO-CH2-; -CH(OH)- CH2-: -CH2-CH2-; -CH=CH-; -C IDENTICAL C-;   - X represents hydrogen or a halogen;   - Y is a cyclohexyl group or, when X is hydrogen, a phenyl group; as well as their salts with inorganic or organic acids.
Patent FI-912988-A0 (FI)
Inventor: DERRICK ARTHUR PERCY
IPC: D21H17/43
Filed: 1991-06-19
Abstract: The fines retention or drainage properties of mechanical pulps in the paper making process are improved by including in the thin stock, not after the last point of high shear, particles of a water-dispersible colloid siliceous material such as a bentonite clay in intimate association with a low molecular weight water soluble high anionic charge density polymer, such as polyacrylic acid having a molecular weight below 50,000 and a charge density of at least 4 m eq/g and further including in the thin stock, after the last point of high shear, a non-ionic high molecular weight polyelectrolyte such as polyacrylamide having a molecular weight of at least 100,000.
Patent FI-915850-A0 (FI)
Inventor: SCHLIPF MICHAEL
IPC: C08F214/18
Filed: 1991-12-12
Abstract: A crosslinkable, fluorine-containing copolymer is described which comprises a) from 10 to 60 mol-% of copolymerized units of a vinyl ester of a highly branched carboxylic acid whose acyl radical has 9 carbon atoms and comprises isomers containing two quaternary carbon atoms to which from 0 to 80 mol-% of isomers containing one quaternary carbon atom together with at least one tertiary carbon atom in the acyl radical are admixed, b) from 20 to 50 mol-% of copolymerized units of a vinyl ester of a short-chain carboxylic acid, where from 50 to 100% of the copolymerized units of this vinyl ester b) are in the OH form obtained by hydrolysis, and c) copolymerized units of a perfluoroolefin of the formula CF2=CFRf  in which Rf is F or a perfluoroalkyl radical having 1 to 8 carbon atoms, in an amount which makes the sum of components a)+b)+c) up to 100 mol-%, but with the proviso that at least 10 mol-% of the perfluoroolefin are present in the copolymer. The copolymers are suitable as binders for surface coating compositions of all types, in particular for industrial finishes.
Patent FI-924402-A0 (FI)
Inventor: AKIN OKAN
IPC: C23C18/08
Filed: 1992-09-30
Abstract: A fluid, viscous coating layer composed of substances that can be solidified is applied at least on the inner side of a metallic tube. During a later processing step, this coating layer is transformed into a permanent, solid layer.
Patent FI-925120-A0 (FI)
Inventor: MARTIN KARL-HEINZ
IPC: F16L39/00
Filed: 1992-11-11
Abstract: A coupling system for pipes is described, which prevents pipes which are not associated with one another being connected, in that a plug nipple (1-3, 1-6) which is connected to a pipe and a coupling (2-3, 2-6) which is connected to the other pipe are provided, the two of which, when joined together, have a defined overall length which corresponds, for example, precisely to the distance between two holding parts (4, 5) of a holder (3) into which the joined-together coupling elements are inserted with the pipes which are connected via them. All the plug nipples and coupling parts in each case have different individual lengths, so that the overall length of coupling elements which are joined together but which are not associated with one another differs from the predetermined length, as a result of which, for example, insertion of the coupling elements which are connected to one another into the holder becomes impossible. 
<IMAGE>
Patent FI-930038-A0 (FI)
Inventor: CORMIER MICHEL J-N
IPC: A61K31/00
Filed: 1993-01-05
Abstract: The present invention provides a method of reducing or preventing skin irritation of a weak base drug by inhibiting the accumulation of the drug in the lysosomes. The drug is irritating to humans, i.e., the drug is susceptible to inducing skin or mucosa irritation in a human when the drug is transdermally administered to the human at a therapeutically effective rate. Irritation reduction or prevention is induced by coadministering to the skin or mucosa of the human: (a) a therapeutically effective amount of a weak base drug which is irritating to humans, at a therapeutically effective rate over a predetermined period of time; and (b) an effective amount of an agent capable of inhibiting the lysosomal uptake of the drug to reduce or prevent irritation to the skin or mucosa.
Patent FI-933754-A0 (FI)
Inventor: GODEK DENNIS MICHAEL
IPC: C07D471/04
Filed: 1993-08-26
Abstract: (C1-C3)Alkyl-4,6,7,8,9,9a-hexahydro-2H,3H-pyrido-[1,2-a]pyrazin-1-one- 7-carboxylate esters, important precursors to certain bis-aza-bicyclic anxiolytics, can be prepared from di(C1-C3)alkyl cis-piperidine-2,5-dicarboxylate starting material by a new process via a new class of intermediates, di(C1-C3)alkyl cis-N-(2-(phthalimido)ethyl)piperidine-2,5-dicarboxylates. In the process, the starting material is reacted with either 2-(phthalimido)ethyl triflate or 2-(phthalimido)acetaldehyde to form the new intermediate, which can then be cyclized to the aforementioned precursor.
Patent FI-935381-A0 (FI)
Inventor: CHEN SHU-HUI
IPC: A61K31/337
Filed: 1993-12-01
Abstract: The present invention provides paclitaxel derivatives of formula I   <CHEM>  in which   R<1> is   -COR<z> in which R<z> is RO- or R; R<2> is   C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, C3-6 cycloalkyl, or a radical of the formula -W-R<x> in which W is a bond, C2-6 alkenediyl, or -(CH2)t-, in which t is one to six; and R<x> is naphthyl, phenyl, or heteroaryl, and furthermore R<x> can be optionally substituted with one to three same or different C1-6 alkyl, C1-6 alkoxy, halogen or -CF3 groups; R<a> is   -OCOR, H, OH, -OR, -OSO2R, -OCONR<o>R, -OCONHR, -OCOO(CH2)tR, or -OCOOR; R<b> and R<c>   are both hydroxy or together form a bond with the carbon atoms to which they are attached; and R and R<o>   are independently C1-6 alkyl, C2-6 alkenyl, C3-6 cycloalkyl, C2-6 alkynyl, or phenyl, optionally substituted with one to three same or different C1-6 alkyl, C1-6 alkoxy, halogen or -CF3 groups.   Also provided by this invention are pharmaceutical formulations (compositions) and a method of treating mammalian tumors with a compound of formula I.
Patent FI-955659-A0 (FI)
Inventor: HYPPAENEN TIMO
IPC: B01J/
Filed: 1995-11-24
Abstract: Particles in a fluidized bed reactor (e.g. a circulating fluidized bed reactor) are discharged from the reactor chamber and then cooled (heat is recovered from them) in a processing chamber. This is accomplished in a particularly advantageous way by discharging the particles from the reactor chamber at a first level (e.g. through a non-mechanical seal or a classifying wall) into a lifting chamber. Upwardly flowing gas in the lifting chamber entrains the particles and lifts them into the processing chamber. After processing, the particles in the processing chamber are returned to the reactor chamber at level higher than the first level, at which point the pressure in the processing chamber is higher than the pressure in the reactor chamber. The particles may be classified in the lifting chamber by utilizing fluidizing gas to transport solid particles smaller than a predetermined size to the processing chamber while discharging larger particles from the bottom of the lifting chamber.
Patent FI-961662-A0 (FI)
Inventor: JORDAN HOLGER
IPC: F16J15/3236
Filed: 1996-04-16
Abstract: PCT No. PCT/DE94/01231 Sec. 371 Date Apr. 10, 1996 Sec. 102(e) Date Apr. 10, 1996 PCT Filed Oct. 18, 1994 PCT Pub. No. WO95/11395 PCT Pub. Date Apr. 27, 1995A rubber elastic sealing ring 13 is arranged between two concentric machine parts 11, 12 moved towards each other. The sealing ring 13 has a surface 22 that on the one hand ends in a dynamic sealing edge 21 and on the other hand extends to the low pressure side N. In addition, an outer peripheral surface 25 of the sealing ring 13 is inclined towards the bottom 18 of the groove in the non-compressed state of the sealing ring 13. Imaginary planes 35, 36 extend through the ring-shaped conical surfaces 22, 25. The imaginary planes 35, 36 are also conical ring-shaped surfaces that form an intersection line 37. The intersection line 37 is always located between one plane 34 (ring-shaped surface) and the peripheral surface 15 of the second machine part 12.
Patent FI-971536-A0 (FI)
Inventor: MORRIS CHARLES F
IPC: C12N15/09
Filed: 1997-04-11
Abstract: A method and pharmaceutical compositions are described for the use of keratinocyte growth factor to treat diabetes in mammals.
Patent FI-991186-A0 (FI)
Inventor: EHSANI NEDA
IPC: A23L1/30
Filed: 1999-05-25
Abstract: A method for treating defatted colostrum with cross flow microfiltration to reduce the bioburden while retaining a high active protein content is described. The method is especially useful for recovering maximum immunoglobulin activity. The colostrum treated by the method is useful in the manufacture of clinical nutritive preparation, functional foods and food supplements.
Patent AP-9701075-A0 (AP)
Title: Spirocyclic dopamine receptor subtype ligands.
Inventor: BUTLER TODD WILLIAM
IPC: C07D295/112
Filed: 1997-08-21
Abstract: This invention relates to novel, pharmaceutically active compounds of the formula i wherein a,b and r1 through r6 are defined as i n the specification. These compounds exhibit central dopaminergic activity and are useful in the treatment of cns disorders.
Patent IL-62853-A0 (IL)
Title: Phenylbenzoylureas,their production and their use as pesticides
IPC: C07D213/64
Filed: 1981-05-12
Abstract: Novel substituted N-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy)-phenyl-N'-benzoylureas of the formula   <IMAGE>   wherein R1 is fluorine, chlorine, bromine or methyl, and R2 is hydrogen, fluorine, chlorine or bromine, processes for producing these compounds and compositions containing them for use in combating pests, particularly in combating insects which infest plants and animals. The novel compounds are especially effective against larval stages of insects which damage plants by eating.
Patent IL-68165-A0 (IL)
Title: Preparation of 4-hydroxy-3-(heterocyclocarbamoyl)-2h-1,2-benzothiazine-1,1-dioxides
IPC: C07D417/12
Filed: 1983-03-17
Abstract: The present invention provides a process for the preparation of 4-hydroxy-3-(heterocyclocarbamoyl)-2H-1,2-benzothiazine-1,1-dioxides of the general formula:   <IMAGE>   wherein R1 is a hydrogen atom or a methyl radical, R2 is a nitrogen-containing heterocyclic radical and R3 is a hydrogen or halogen atom or a methyl radical, and of the alkali metal, alkaline earth metal and amine salts thereof, by the reaction of an amine-substituted, nitrogen-containing heterocyclic compound with a halo-acetyl halide, reaction of the intermediate thus obtained with sodium benzoic acid sulphimide, ring expansion of the benzoisothiazole ring to give a benzothiazine ring and, in case R2 is to be an isoxazolyl radical, reverse rearrangement of the oxadiazole-ring formed by ring expansion to the isoxazolyl ring, wherein (in a one-pot reaction A) the reaction of an amine-substituted, nitrogen-containing heterocyclic compound with a halo-acetyl halide is carried out, without the addition of a base, in boiling ethyl acetate, the intermediate formed is, without isolation, reacted with sodium benzoic acid sulphimide and the reaction product isolated, whereafter, in a one-pot reaction B, the reaction product from the one-pot reaction A is reacted in a dipolar aprotonic solvent under an atmosphere of a protection gas with a strongly basic alkali-alkohole and thereafter with so much acid that about 2 equivalents of base remained unneutralized in the reaction solution and, if desired, the benzothiazine ring is N-methylated in the usual manner and the product obtained is, if desired, converted in known manner into an alkali metal, alkaline earth metal or amine salt.
Patent IL-72719-A0 (IL)
Title: Preparation of alpha-chlorinated chloroformates
IPC: C07C69/96
Filed: 1984-08-17
Abstract: Process for the preparation of  alpha -chlorinated chloroformates with the formula   <IMAGE>   where R is H, an aliphatic or aromatic hydrocarbon radical or heterocyclic radical, substituted or non-substituted and n an integer. The process consists of reacting ClCOOCCl3 or Cl3COCOOCCl3 with an aldehyde with formula R-(CHO)n in the presence of a compound, which in the medium releases a pair of ions, the anion of which being a halide which can attack the aldehyde function, because of the weak attractive power of the cation of this compound.
Patent IL-76520-A0 (IL)
Title: Preparation of 1,2-benzoxathiine derivatives
IPC: C07D327/06
Filed: 1985-09-27
Abstract: A novel process for the preparation of 3,4-dihydro-2,2-dioxo-3-methyl-1,2-benzoxathiin-8-ylsulfonamide of the formula I    <IMAGE>  (I)  reacting a 5-halo-2,3-dihydro-2-methylbenzo[b]furan of the formula II    <IMAGE> (II)  wherein Hal is chlorine or bromine, with chlorosulfonic acid to give a 6-halo-2,2-dioxo-3-methyl-1,2-benzoxathiin-8-ylsulfonyl chloride of formula III    <IMAGE> (III)   wherein Hal is chlorine or bromine, converting this sulfonyl chloride with ammonia into a 6-halo-2,2-dioxo-3-methyl-1,2-benzoxathiin-8-ylsulfonamide of formula IV    <IMAGE> (IV)  wherein Hal is chlorine or bromine, dehalogenating this sulfonamide with hydrogen in the presence of a tertiary amine and a noble metal catalyst, and hydrogenating the resultant 2,2-dioxo-3-methyl-1,2-benzoxathiin-8-ylsulfonamide of formula V    <IMAGE> (V)  with hydrogen in the presence of a noble metal catalyst.
Patent IL-83786-A0 (IL)
Title: Stable hydrate of a penicillin derivative and its preparation
IPC: A61P31/04
Filed: 1987-09-04
Abstract: A stable trihydrate of (2S, 5R, 6R)-6-{(2R)-2-[(2R)-2-amino-3-(N-methylcarbamoyl)propionamido]-2-(p-hyd oxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabic yclo[3.2.0]heptane-2-carboxylic acid and process for preparing the same are disclosed.
Patent IL-104775-A0 (IL)
Title: Pharmaceutical compositions containing triazine derivatives
IPC: A61P25/04
Filed: 1993-02-18
Abstract: The present invention relates to the use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine and its pharmaceutically and veterinarily acceptable acid addition salts in therapy.
Patent IL-110825-A0 (IL)
Title: Pharmaceutical compositions comprising a substituted cyclodextrin and cytotoxic compound
IPC: A61K47/40
Filed: 1994-08-30
Abstract: Compositions of matter comprising a substituted cyclodextrin and cytotoxic compound, especially cytotoxic drugs such as antibiotic, anti-fungal and anti-neoplastic, drugs are claimed. The compositions cause significantly less ulceration compared to the same formulation of cytotoxic compound without cyclodextrin compound when extravasated. The compositions may also cause less vascular irritation compared to the same formulation of cytotoxic compound without cyclodextrin when administered intravenously without extravasation. Compositions of matter comprising watersoluble cytotoxic agents, especially anticancer drugs and anti-ulceration effective or anti-irritatioin effective amounts of cyclodextrin compounds are also claimed. Methods for reducing the likelihood of ulceration and or irritation when administering the compositions according to the invention are also disclosed and claimed.
Patent IL-111891-A0 (IL)
Title: Astigmatic correcting intracorneal ring
IPC: A61F9/007
Filed: 1994-12-06
Abstract: This invention is an intrastromal corneal ring ("ICR") which is not uniform in dimension. It has, typically, two or more raised areas (or areas of additional bulk) spaced apart from each other on the ring. This ring design, when introduced into the stroma and properly adjusted there, permits at least partial correction of astigmatism in the eye.
Patent IL-112056-A0 (IL)
Title: Method and apparatus for performing a fast hadamard transform
IPC: G06F17/14
Filed: 1994-12-19
Abstract: A method and apparatus are provided for performing a Hadamard transform operation. The basic building block of the apparatus is an FHT engine having a difference circuit for subtracting the input symbol from a delayed processed symbol, first multiplexer for providing either the difference of the delayed processed symbol and the input symbol or the input symbol, a summing circuit for adding the input symbol to the delayed processed symbol and a second multiplexer for providing either the sum of the input and the delayed processed symbol or the delayed processed symbol as an output. This basic engine is designed to work in conjunction with a variety of different memory configurations. The engines can then be placed in series to perform a Hadamard transform of all defined orders. In addition, two methods of optimizing the use of memory resources are described. On involves the optimal configuration of the memory elements and the second involves truncation. Also, provided is a method and apparatus for performing the transform on samples provided as a serial bit stream to the apparatus.
Patent IL-113166-A0 (IL)
Title: Polymeric cation exchange membranes processes for the preparation thereof and electrochemical apparatus utilizing the same
IPC: H01M50/497
Filed: 1995-03-28
Abstract: A modified polymeric cation exchange membrane for use in an electrochemical cell, the membrane having a salt selected from the group consisting of silver, tungsten, molybdenum and a mixture thereof deposited within the polymer matrix, the salt being insoluble in the electrolytes which, in use, contact either side of the membrane. The membranes are of particular use in electrochemical cells and combine a low electrolytic resistivity with a high permselectivity.